Tolterodine

Chemical formula: C₂₂H₃₁NO  Molecular mass: 325.488 g/mol  PubChem compound: 443879

Therapeutic indications

Tolterodine is indicated for:

Urge incontinence, increased urinary frequency, increased urinary urgency

Population group: only adults (18 years old or older)

Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tolterodine is contraindicated in the following cases:

Urinary retention

Retention of urine

Uncontrolled narrow angle glaucoma

Angle-closure glaucoma

Myasthenia gravis

Myasthenia gravis

Severe ulcerative colitis

Colitis gravis

Toxic megacolon

† Toxic megacolon

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: DETROL LA Capsule
Summary of Product Characteristics (SPC) 2022: TOLTERODINE ACCORD Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈